Philip Morris International’s Moira Gilchrist Positions Human Judgment as a Critical Leadership Advantage Amid Rapid AI Adoption at Wall Street Journal Forum
Philip Morris International’s (PMI) (
NYSE:PM) Chief Global Communications Officer, Moira Gilchrist, joined global thought leaders at The Wall Street Journal’s Future of Everything conference in New York to examine why human cognition—judgment, context, creativity, and ethical reasoning—is becoming the most valuable asset in an age of artificial intelligence.
Forbes Includes Philip Morris International in Its Net Zero Leaders List
Philip Morris International (PMI) (
NYSE: PM) has been included once more in Forbes’ 2026 Net Zero Leaders1 list, recognizing its leadership and continued progress in advancing climate action across its global operations.
Philip Morris International Expands its Partnership with Ducati Corse as Decades-Long Partnership Races Forward with Purpose
Philip Morris International1 (
NYSE: PM) today announced an expanded partnership with Ducati Corse for the 2026 season and beyond. This next chapter introduces a major development: the ZYN brand of nicotine pouches—the number one nicotine pouch brand globally2—will feature on Ducati Corse MotoGP liveries at select races throughout the seasons.
IQOS and Devialet Introduce “Soundsorial Design” Collaboration
Philip Morris International (
NYSE: PM) today announced a collaboration between IQOS – the number 1 tobacco heating system1, and Devialet – the French acoustic engineering company, launching “Soundsorial Design” at Milan Design Week 2026.
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes.
One in Three Cigarettes in the Region of The Americas in 2025 Is Illicit, New Study Finds
Philip Morris International (
NYSE: PM) today emphasizes the importance of effective policymaking in responding to the growing illicit tobacco trade in the Region of the Americas (excluding the United States), where almost one out of every three cigarettes consumed across 11 countries in the region comes from illegal sources.
Philip Morris International Joins Ferrari Hypersail as Principal Partner, Building on 50-Year Relationship
Philip Morris International (
NYSE: PM) today announced it will serve as Principal Partner of Ferrari Hypersail, an initiative that applies Ferrari engineering and racing spirit to a new frontier at sea. PMI has shared with Ferrari one of the most enduring partnerships in Formula 1 since its origins in 1973 - a relationship defined by reinvention, ambition, and an unwavering belief that progress matters. Philip Morris International’s commitment to science-backed innovation, including smoke-free technologies, echoes the same passion for progress that propels Ferrari Hypersail.
Philip Morris International Presents its Value Report 2025: change in motion
Philip Morris International (
NYSE: PM) today released its Value Report 2025, offering a holistic perspective on the company’s approach to sustainable value creation. The report marks the completion of PMI’s 2025 Roadmap, communicating achievements for each aspiration introduced by the company in 2020, and introduces its Value Plan 2030+, set to guide the company’s continued path to sustainable growth.
Philip Morris International Urges FDA Advisory Committee to Recommend Authorizing ZYN as a Modified Risk Tobacco Product
Experts from Philip Morris International (PMI) (
NYSE: PM) yesterday presented scientific evidence to the U.S. Food and Drug Administration’s (FDA) Tobacco Products Scientific Advisory Committee (TPSAC) as part of the FDA’s process for a Modified Risk Tobacco Product (MRTP) designation for their ZYN nicotine pouch products. This designation would allow PMI’s U.S. family of businesses to communicate to U.S. legal-aged, 21+ adult cigarette smokers that switching completely to ZYN reduces their risk of many smoking-related diseases and we look forward to a decision by FDA.
Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI
Philip Morris International Inc. (
NYSE: PM) today released a new white paper, “Human Cognition: The Next Frontier?”, inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy.
PMI is Invested in America: Already Over $20 Billion of U.S.-Related Investments with Significant Further Amounts Planned
Philip Morris International (
NYSE: PM) and its U.S. businesses (PMI U.S.) are strongly committed to investing in America, with over $20 billion of PMI investments since 2022 majority-related to both acquiring and further investing in U.S. manufacturing capabilities, commercial rights and infrastructure, and U.S. jobs.
Philip Morris International Expands its Partnership with Scuderia Ferrari HP, Launching a Bold New Chapter in Their Long-Standing Relationship
Philip Morris International Inc. (
NYSE: PM) today announced an expanded partnership with Scuderia Ferrari HP and with Ferrari Challenge Trofeo Pirelli—the single-marque motorsport championship created in 1993—for the 2026 season and beyond. This next chapter introduces one major development: the ZYN brand of nicotine pouches—the number one nicotine pouch brand globally1—will feature on Scuderia Ferrari HP Formula 1 liveries at select races throughout the seasons.
Philip Morris International Publishes Updated Climate Transition Plan to Achieve Net Zero by 2040
Philip Morris International Inc. (PMI) (
NYSE: PM) today announced the release of its second Climate Transition Plan (CTP 2025), presenting an updated and integrated strategy to achieve net-zero greenhouse gas (GHG) emissions across its value chain by 2040.
Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product
Experts from Philip Morris International Inc. (
NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP).
Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking
A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (
NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes and growing worries about how public health decisions are made.
Philip Morris International Releases 2025 Sustainability Materiality Report
Philip Morris International Inc. (
NYSE: PM) today published its 2025 Sustainability Materiality Report, presenting the results of its latest global sustainability materiality assessment (SMA). Following the principles of double materiality, the report outlines the key sustainability topics identified, along with their associated impacts, risks, and opportunities (IROs), in line with the EU Corporate Sustainability Reporting Directive (CSRD). Consumers and end users remain the company’s core priority, with a focus on product health impact and ensuring responsible marketing and sales.
Invested in America: Philip Morris International Highlights Bold Commitment to America Through New National Ad Campaign
Today, Philip Morris International’s U.S. businesses (“PMI U.S.”) unveiled “Invested in America,” a bold advertising campaign that brings to life the company’s deep-rooted commitment and increased contributions to America and Americans. The campaign’s message is grounded in the role PMI U.S. is playing in powering job growth, revitalizing manufacturing, improving public health by offering adults 21+ who smoke better choices, and strengthening communities across the nation.
Illicit Cigarettes in European Union at Highest Level Since 2015, KPMG Study Shows
Philip Morris International Inc. (
NYSE: PM) today issues an urgent call for effective policymaking to counter the growing threat of illicit trade in the EU. In 2024, 38.9 billion illicit cigarettes were consumed in the region—the highest level since 2015—accounting for 9.2% of total cigarette consumption, with governments losing as much as €14.9 billion in tax revenues at a time when many countries face intense economic pressures.
Two-Thirds of U.S. Healthcare Practitioners Mistakenly Believe or Are Unsure Whether Nicotine Causes Cancer, According to New Survey
A new survey, funded by Philip Morris International’s U.S. affiliates (PMI U.S.), has found that 47% of U.S. healthcare practitioners—rising to 59% among medical professionals who indicate that half or more of their patients smoke cigarettes—mistakenly believe nicotine is a carcinogen, despite scientific consensus that the harms of smoking primarily stem not from nicotine but from the burning of tobacco. Another 19% are unsure. Practitioners surveyed generally agree that smoke-free products—such as nicotine pouches and other noncombustible alternatives—are addictive and not risk-free, but still pose less risk than cigarettes. However, the survey results also show that misconceptions about nicotine persist and are obstructing progress on tobacco harm reduction.
Philip Morris International CEO Jacek Olczak Addresses Emerging Global Divide in Regulatory Approaches to Consumer Innovation
Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (
NYSE: PM), outlined the need for common-sense regulations in the consumer goods sector while addressing global leaders at Semafor’s annual World Economy Summit in Washington, D.C., on April 25, 2025. Olczak emphasized the sector’s potential for innovation-led growth despite the volatile economic environment. He stressed, however, that without appropriate regulation and policy frameworks to enable scientific evaluation and consumer access, promising breakthroughs—such as innovations in wellness, food, and personal care products—could become missed opportunities.
IQOS Collaborates with Italian Design Brand SELETTI: Introducing the 'Curious X: Sensorium Piazza' at Milan Design Week
In support of Philip Morris International’s (
NYSE: PM) mission to make cigarettes obsolete, and to celebrate its ever-growing community of more than 32 million users worldwide – IQOS is proud to announce its collaboration with iconic design brand SELETTI at Milan Design Week.
Philip Morris International Releases Integrated Report Detailing Progress Towards Its Smoke-Free Vision
Philip Morris International Inc. (
NYSE: PM) today published its sixth annual Integrated Report, marking the company’s 10th year of business transformation and sustainability disclosures. The document details PMI’s continued progress in delivering long-term value to shareholders and other stakeholders while advancing its purpose of having its smoke-free alternatives make cigarettes obsolete as soon as possible.
Multinational Survey by Philip Morris International Demonstrates Need for Greater Collaboration to Advance Innovation
The challenges facing our world can overwhelm, but most people strongly believe in innovation’s potential to address the most critical issues in the next 10–20 years, according to the results of a new independent survey commissioned by Philip Morris International Inc. (
NYSE: PM). Conducted by Povaddo in 10 countries in Africa, the Americas, Asia, and Europe, the survey and resultant white paper “Innovation Under Pressure: Navigating Complexity to Drive Change” explore the challenges innovation must overcome to drive societal change, including misinformation, outdated biases, and policymakers’ inability to keep up with rapid technological advances.
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+.
New Megatrends author Marian Salzman predicts 2025 will see us burrowing in, curbing tech, and pursuing delight
Creator of the world’s first online focus groups (via AOL dial-up modems in the 1990s), bestselling author Marian Salzman has been #trending for 30 years with predictions encompassing everything from sleep as the new sex to metrosexuality, “brand me,” and the rise of singletons.
Philip Morris International Marks a Decade of IQOS—a Milestone in the Journey to a Smoke-Free Future
Philip Morris International Inc. (PMI) (
NYSE: PM) marks the 10th anniversary of the introduction of its leading smoke-free product, IQOS. The launch of this smoke-free innovation was a breakthrough moment toward achieving the company’s commitment to a future without cigarettes.
Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex
Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (
NYSE: PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and the establishment of master service agreements to develop Vectura Fertin Pharma’s inhaled therapeutics proprietary pipeline. Vectura will be operated by Phillips Medisize, a Molex company. The sale includes upfront cash consideration of GBP 150 million, subject to customary purchase price adjustments, and potential deferred payments of up to GBP 148 million. The transaction is subject to customary closing conditions, including regulatory approval.
New KPMG Report Shows Illicit Cigarette Consumption Still at Worrying Levels in the European Union, With Organized Crime Moving Operations Closer to Western Countries
Philip Morris International Inc. (PMI) (
NYSE: PM) today warns about the high levels of contraband and counterfeit cigarettes in the European Union (EU) year over year, with 35.2 billion illicit cigarettes consumed in the region in 2023, accounting for 8.3% of total consumption in the EU, an increase of 0.1 percentage point compared to 2022.
Philip Morris International’s Swedish Match Affiliate Adding 450 Jobs with $232 Million Investment in Kentucky
Philip Morris International Inc. (PMI) (
NYSE: PM) is announcing an investment of $232 million through one of its Swedish Match affiliates to expand production capacity of its manufacturing facility in Owensboro, Ky. The expansion is expected to create an additional 450 direct jobs with an ongoing annual economic impact of $277 million and an additional 410 indirect jobs* for the commonwealth of Kentucky. The facility produces ZYN nicotine pouches to help meet the growing demand from legal-age consumers switching from cigarettes or other traditional tobacco products.
Philip Morris International U.S. Affiliate to Create 500 Jobs Investing $600 Million in Aurora, Colo., Manufacturing Facility
Today, Philip Morris International Inc. (PMI) (
NYSE: PM) announced an investment of $600 million over the next two years through one of its U.S. affiliates to open a state-of-the-art manufacturing facility in Aurora, Colo. The facility is expected to create 500 direct jobs with ongoing annual economic impact of $550 million and an additional 1,000 indirect jobs* for the State of Colorado as it produces Swedish Match ZYN nicotine pouches to help meet the growing global demand from legal-age consumers for smoke-free products.
Swedish Match USA, Inc. Presents to U.S. Food and Drug Administration Advisory Committee to Renew Modified Risk Claim for General Snus
Experts from Swedish Match USA, Inc., an affiliate of Philip Morris International Inc. (
NYSE: PM) (PMI), presented to the Tobacco Products Scientific Advisory Committee (TPSAC) on June 26, 2024. The committee, comprised of independent scientific researchers, provides regulatory guidance to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products.
